User profiles for Nikoletta Rovina

Nikoletta Rovina

Lecturer in Pulmonology, University of Athens
Verified email at med.uoa.gr
Cited by 6663

[HTML][HTML] Inflammation and immune response in COPD: where do we stand?

N Rovina, A Koutsoukou, NG Koulouris - Mediators of inflammation, 2013 - hindawi.com
Increasing evidence indicates that chronic inflammatory and immune responses play key roles
in the development and progression of COPD. Recent data provide evidence for a role in …

Critically ill cancer patient in intensive care unit: issues that arise

E Kostakou, N Rovina, M Kyriakopoulou… - Journal of critical …, 2014 - Elsevier
Advances in the management of malignancies and organ failures have led to substantial
increases in survival as well as in the number of cancer patients requiring intensive care unit (…

[HTML][HTML] Smoking cessation in pregnancy: An update for maternity care practitioners

…, S Papadakis, S Schoretsaniti, N Rovina… - Tobacco induced …, 2019 - ncbi.nlm.nih.gov
RESULTS There is strong evidence of the effects of maternal tobacco use and secondhand
smoke exposure on adverse pregnancy outcomes. Tobacco use is the leading preventable …

[PDF][PDF] Complex immune dysregulation in COVID-19 patients with severe respiratory failure

EJ Giamarellos-Bourboulis, MG Netea, N Rovina… - Cell host & …, 2020 - cell.com
Proper management of COVID-19 mandates better understanding of disease pathogenesis.
The sudden clinical deterioration 7–8 days after initial symptom onset suggests that severe …

[HTML][HTML] Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison

IE Galani, N Rovina, V Lampropoulou… - Nature …, 2021 - nature.com
A central paradigm of immunity is that interferon (IFN)-mediated antiviral responses precede
pro-inflammatory ones, optimizing host protection and minimizing collateral damage 1 , 2 . …

[HTML][HTML] Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients

…, M Herbert, L Holsten, A Horne, ID Gemünd, N Rovina… - Genome medicine, 2021 - Springer
Background The SARS-CoV-2 pandemic is currently leading to increasing numbers of
COVID-19 patients all over the world. Clinical presentations range from asymptomatic, mild …

[HTML][HTML] Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia

N Rovina, K Akinosoglou, J Eugen-Olsen, S Hayek… - Critical Care, 2020 - Springer
As of April 1, 2020, 885,689 cases of infections by the novel coronavirus SARS-CoV-2 (COVID-19)
have been recorded worldwide; 44,217 of them have died (https://www. worldometers…

[HTML][HTML] Macrophage activation-like syndrome: an immunological entity associated with rapid progression to death in sepsis

…, G Dimopoulos, A Pantazi, SE Orfanos, N Rovina… - BMC medicine, 2017 - Springer
Background A subanalysis of a randomized clinical trial indicated sepsis survival benefit
from interleukin (IL)-1 blockade in patients with features of the macrophage activation-like …

[HTML][HTML] Interleukin-18 in induced sputum: association with lung function in chronic obstructive pulmonary disease

N Rovina, E Dima, C Gerassimou, A Kollintza… - Respiratory …, 2009 - Elsevier
BACKGROUND: It has been shown that interleukin (IL)-18 levels in induced sputum are
reduced in asthmatic and healthy smokers. However, in chronic obstructive pulmonary disease (…

[HTML][HTML] Physical activity: a missing link in asthma care

M Panagiotou, NG Koulouris, N Rovina - Journal of clinical medicine, 2020 - mdpi.com
Asthma is the commonest respiratory disease and one of unceasingly increasing prevalence
and burden. As such, asthma has attracted a major share or scientific interest and clinical …